Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Quidel and Ortho Announce Expected Closing of Ortho Transaction
Quidel and Ortho Announce Expected Closing of Ortho Transaction


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, and Ortho Clinical Diagnostics

AMN Healthcare Honored as Prime Supplier of the Year for Work with Minority-Owned Businesses
AMN Healthcare Honored as Prime Supplier of the Year for Work with Minority-Owned Businesses


AMN Healthcare, the nation’s leader in healthcare total talent solutions, has been named Prime Supplier of the Year by the Western Regional Minority Supplier Development Council for prioritizing

Simulations Plus Releases ADMET Predictor Version 10.4 (X.4)
Simulations Plus Releases ADMET Predictor Version 10.4 (X.4)


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical and biotechnology industries, today announced the release of version 10.4 (X.4)

LivaNova to Present at the Goldman Sachs Global Healthcare Conference
LivaNova to Present at the Goldman Sachs Global Healthcare Conference


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced Damien McDonald, Chief Executive Officer, will present in a fireside chat at the Goldman

Agilent Reports Second-Quarter Fiscal Year 2022 Financial Results: https://unsplash.com/photos/WUehAgqO5hE
Agilent Reports Second-Quarter Fiscal Year 2022 Financial Results


Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.61 billion for the second quarter ended April 30, 2022, an increase of 5% compared to the second quarter of 2021 and up 7% on a core

Quotient Appoints Kimberly Anstett to its Board of Directors
Quotient Appoints Kimberly Anstett to its Board of Directors


Quotient Technology Inc. (NYSE: QUOT) (“Quotient” or the “Company”), the leading digital media and promotions technology company, today announced that it has appointed Kimberly Anstett to the

Dexcom Announces Upcoming Conference Presentation
Dexcom Announces Upcoming Conference Presentation


DexCom, Inc. (NASDAQ:DXCM) today announced that Brice Bobzien, Senior Vice President, Finance, will present an update on the company at the Piper Sandler Ophthalmology and Diabetes Symposium on

NanoString Launches Integrated Informatics to Facilitate Spatial Biology Research Using Next Generation Sequencing
NanoString Launches Integrated Informatics to Facilitate Spatial Biology Research Using Next Generation Sequencing


NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a seamless, cloud-based workflow that improves the

DGAP-News: M1 Kliniken AG announces financials for Q1-2022: further growth of Beauty segment; ongoing optimisation of Trade segment
DGAP-News: M1 Kliniken AG announces financials for Q1-2022: further growth of Beauty segment; ongoing optimisation of Trade segment
DGAP-News: M1 Kliniken AG announces financials for Q1-2022: further growth of Beauty segment; ongoing optimisation of Trade segment
Straumann Group to acquire PlusDental, a doctor-led clear-aligner treatment solutions provider in Europe
Straumann Group to acquire PlusDental, a doctor-led clear-aligner treatment solutions provider in Europe
Straumann Group to acquire PlusDental, a doctor-led clear-aligner treatment solutions provider in Europe
Agilent Announces Cash Dividend of 21 Cents per Share
Agilent Announces Cash Dividend of 21 Cents per Share


Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 21 cents per share of common stock will be paid on July 27, 2022, to all shareholders of record as of the close of

AMN Highest Ranked Healthcare MSP in 2022 Global Customer Satisfaction Awards
AMN Highest Ranked Healthcare MSP in 2022 Global Customer Satisfaction Awards


AMN Healthcare (NYSE: AMN), the nation’s leader in healthcare total talent solutions, achieved the highest ranking for a healthcare Managed Services Program in the HRO Today 2022 Baker’s Dozen

Financial year 2021/22: Sonova delivers solid results
and significantly advances its growth strategy
Financial year 2021/22: Sonova delivers solid results and significantly advances its growth strategy
Financial year 2021/22: Sonova delivers solid results and significantly advances its growth strategy
Quidel Announces Stockholder Approval of Ortho Acquisition and Business Combination
Quidel Announces Stockholder Approval of Ortho Acquisition and Business Combination


Quidel Corporation (Nasdaq: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that the previously

AMN Healthcare Acquires Connetics USA, an International Nurse and Allied Recruitment Company
AMN Healthcare Acquires Connetics USA, an International Nurse and Allied Recruitment Company


AMN Healthcare (NYSE: AMN), the nation’s leading total healthcare talent solutions company, has acquired Connetics USA, an international nurse and allied recruitment company that specializes in

Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend


Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company’s 2022 annual stockholders’ meeting. Each of the directors continues from the prior term.

PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results
PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results


PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors

DGAP-News: Eckert & Ziegler with Sales Growth in the First Quarter of 2022
DGAP-News: Eckert & Ziegler with Sales Growth in the First Quarter of 2022
DGAP-News: Eckert & Ziegler with Sales Growth in the First Quarter of 2022
Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results
Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results


Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”, the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ)

Chemed Corporation to Present at the 2022 RBC Capital Markets Global Healthcare Conference
Chemed Corporation to Present at the 2022 RBC Capital Markets Global Healthcare Conference


Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 18, 2022, at approximately 8:00 a.m. (ET)

Geratherm Medical AG: Voluntary delisting offer by JotWe GmbH published
Geratherm Medical AG: Voluntary delisting offer by JotWe GmbH published
Geratherm Medical AG: Voluntary delisting offer by JotWe GmbH published
DGAP-News: Eckert & Ziegler Cooperates with Czech Research Center UJF to Produce Pharmaceutical Alpha Radioisotopes
DGAP-News: Eckert & Ziegler Cooperates with Czech Research Center UJF to Produce Pharmaceutical Alpha Radioisotopes
DGAP-News: Eckert & Ziegler Cooperates with Czech Research Center UJF to Produce Pharmaceutical Alpha Radioisotopes
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Cervical Cancer: https://unsplash.com/photos/26h317_UMYM
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Cervical Cancer


Agilent Technologies Inc. (NYSE: A) today announced that its PD-L1 IHC 22C3 pharmDx, Code SK006, is now EU CE-IVD–marked for use in cervical cancer. PD-L1 IHC 22C3 pharmDx can be used as an aid in

Humana Specialty Pharmacy Receives Prestigious National Patient Choice Award for Fifth Consecutive Year
Humana Specialty Pharmacy Receives Prestigious National Patient Choice Award for Fifth Consecutive Year


Humana Specialty Pharmacy has won the MMIT Specialty Pharmacy Patient Choice Award in the PBM/Payer category for the fifth year in a row. The award recognizes best-in-class customer satisfaction

Dexcom Announces Upcoming Conference Presentations
Dexcom Announces Upcoming Conference Presentations


DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the following upcoming investor